Sökning: "prostate cancer treatment planning"
Visar resultat 1 - 5 av 23 avhandlingar innehållade orden prostate cancer treatment planning.
1. MRI in prostate cancer : implications for target volume
Sammanfattning : Prostate cancer (PCa) is the most common cancer among men, with 10 000 new cases per year in Sweden [1]. To diagnose PCa, magnetic resonance imaging (MRI) is used to identify and classify the disease. LÄS MER
2. Quality of life and side effects in patients with localized prostate cancer : evaluation with self-assessment questionnaires
Sammanfattning : Localized prostate cancer (LPC) is predominantly a tumor among older men, and few patients will get symptoms from the disease. All methods to treat LPC with a curative intent have different types and degrees of side effects. LÄS MER
3. On Quality in Radiotherapy Treatment Plan Optimisation
Sammanfattning : Radiotherapy is one of the essential treatments used in the fight against cancer. The goal of radiotherapy is to deliver a high dose of ionising radiation to the tumour volume and at the same time minimise the effect on healthy tissue by reducing the radiation to critical organs. LÄS MER
4. Patient Outcomes after Radiotherapy of Prostate Cancer. Impact of Absorbed Dose and Treated Volume
Sammanfattning : Abstract Backgound Prostate cancer is the most common form of cancer in men in Sweden. Radiotherapy, including external beam radiation therapy (EBRT) and brachytherapy (BT), is important treatment alternatives to surgery and active surveillance. LÄS MER
5. Register studies of cancer in the Southern Health Care Region in Sweden
Sammanfattning : The overall aim was to study different aspect of health care use and health care costs on a population based level for persons with cancer and their partners, and from an individual level to explore the impact of comorbidities in incidence and survival. In the beginning of the study all persons in the Southern Health Care Region in Sweden diagnosed with colon, rectal, breast, prostate and lung cancer during the period 2000 to 2005 were identified via the Swedish Cancer Register. LÄS MER